Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.
The results of the Shingles Prevention Study, a Cooperative Studies Program conducted through the US Department of Veterans Affairs, are summarized. Also provided are general recommendations and contraindications for the use of zoster vaccine live among patients aged 60 years or older.
Gelb
Lawrence D
LD
Washington University School of Medicine, Division of Infectious Diseases, St Louis, MO 63110-1010, USA. ldgelb@swbell.net
D000367:Age Factors; D000368:Aged; D006562:Herpes Zoster / Q000453:epidemiology* / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine; D006801:Humans; D015994:Incidence; D008875:Middle Aged
D053061:Herpes Zoster Vaccine